These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 22738821)
1. Biologics against cancer-specific receptors - challenges to personalised medicine from early trial results. Haque SU; Morton D; Welch H Curr Opin Pharmacol; 2012 Aug; 12(4):392-7. PubMed ID: 22738821 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor inhibitors: an update on their development as cancer therapeutics. Seymour L Curr Opin Investig Drugs; 2003 Jun; 4(6):658-66. PubMed ID: 12901223 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities. Modjtahedi H; Essapen S Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350 [TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor antagonism and cancer. Bhalla A; Haque S; Taylor I; Winslet M; Loizidou M Eur J Clin Invest; 2009 Jun; 39 Suppl 2():74-7. PubMed ID: 19335749 [TBL] [Abstract][Full Text] [Related]
6. Biology of interactions: antiepidermal growth factor receptor agents. Harari PM; Allen GW; Bonner JA J Clin Oncol; 2007 Sep; 25(26):4057-65. PubMed ID: 17827454 [TBL] [Abstract][Full Text] [Related]
7. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists. Carducci MA; Jimeno A Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6296s-6300s. PubMed ID: 17062717 [TBL] [Abstract][Full Text] [Related]
9. Progress in cancer chemotherapy with special stress on molecular-targeted therapy. Saijo N Jpn J Clin Oncol; 2010 Sep; 40(9):855-62. PubMed ID: 20651047 [TBL] [Abstract][Full Text] [Related]
11. Advances in chemotherapy against advanced or metastatic colorectal cancer. Omura K Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257 [TBL] [Abstract][Full Text] [Related]
12. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer. Van Cutsem E Oncologist; 2006 Oct; 11(9):1010-7. PubMed ID: 17030643 [TBL] [Abstract][Full Text] [Related]
18. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer. Langer C; Soria JC Clin Lung Cancer; 2010 Mar; 11(2):82-90. PubMed ID: 20199973 [TBL] [Abstract][Full Text] [Related]
19. The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy. Bagnato A; Spinella F; Rosanò L Can J Physiol Pharmacol; 2008 Aug; 86(8):473-84. PubMed ID: 18758494 [TBL] [Abstract][Full Text] [Related]
20. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications. Tortora G; Ciardiello F; Gasparini G Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]